全球科学服务领域的领导者赛默飞世尔与专注于药物输送技术的SHL医疗宣布达成战略合作，旨在为生物制药行业提供端到端的综合药械组合解决方案。此次合作将整合双方在药物开发、医疗器械制造及全球供应链管理方面的核心优势，显著提升从概念到商业化生产的全流程效率。
通过资源共享与技术互补，双方计划缩短创新疗法上市时间，为患者提供更安全、便捷的治疗选择。这一合作模式有望重塑行业标准，推动个性化医疗与精准药物输送技术的发展。
全球科学服务领域的领导者赛默飞世尔与专注于药物输送技术的SHL医疗宣布达成战略合作，旨在为生物制药行业提供端到端的综合药械组合解决方案。此次合作将整合双方在药物开发、医疗器械制造及全球供应链管理方面的核心优势，显著提升从概念到商业化生产的全流程效率。
通过资源共享与技术互补，双方计划缩短创新疗法上市时间，为患者提供更安全、便捷的治疗选择。这一合作模式有望重塑行业标准，推动个性化医疗与精准药物输送技术的发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.